IBRX vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

IBRX

30.1
AI Score
VS
RXRX Wins

RXRX

31.9
AI Score

Investment Advisor Scores

IBRX

30score
Recommendation
AVOID NEW MONEY

RXRX

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric IBRX RXRX Winner
Forward P/E 123.4568 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 93.9% -60.1% IBRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 30.1/100 31.9/100 RXRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

IBRX 1M: +29.4% · 3M: +15.4% RXRX 1M: +21.9% · 3M: +4.0%

Current Technical Phase

IBRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 70

RSI (14): 70.3 · Price: $10.29

RXRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 62

RSI (14): 61.9 · Price: $4.12

Fundamentals Snapshot

Metric IBRX RXRX
Market Cap — —
Forward P/E -81.2 -4.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.9% -0.6%
Gross Margin 1.0% -7.2%
Operating Margin -1.2% -17.6%
EPS -1.02 -0.99
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.